Viewing Study NCT02364206

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2026-03-07 @ 7:05 PM
Study NCT ID: NCT02364206
Status: COMPLETED
Last Update Posted: 2019-08-14
First Post: 2015-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
Sponsor: Centre Jean Perrin
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None newly diagnosed glioblastoma View
None p38 MAPK inhibitor View
None temozolomide View
None radiotherapy View